Letter re: Prophylactic Enoxaparin Dosing Using Anti-Factor Xa Levels in Hepatic Surgery Patients: A Pilot Study

被引：0
|
作者：
Hyon, Stephanie S. [1 ]
Elsawwah, Jana K. [1 ]
Harris, Maia A. [1 ]
Nemeth, Zoltan H. [2 ]
机构：
[1] Morristown Med Ctr, Dept Surg, Morristown, NJ USA
[2] Columbia Univ, Dept Anesthesiol, New York, NY 10027 USA
来源：
AMERICAN SURGEON | 2024年
关键词：
D O I：
10.1177/00031348241275721
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prophylactic Enoxaparin Dosing Using Anti-Factor Xa Levels in Hepatic Surgery Patients: A Pilot Study
    Coster, Samuel
    Shammout, Ali
    Chaney, Michael
    Folkert, Kyra
    Grosh, Kent
    Shebrain, Saad
    Munene, Gitonga
    [J]. AMERICAN SURGEON, 2024, 90 (06) : 1760 - 1762
  • [2] Multicenter study evaluating target attainment of anti-Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients
    Chanas, Tyler
    Gibson, Gabrielle
    Langenstroer, Elizabeth
    Herrmann, David J.
    Carver, Thomas W.
    Alexander, Kaitlin
    Chui, Sai Ho Jason
    Rein, Lisa
    Ha, Michael
    Maynard, Kaylee M.
    Bamberg, Kristen
    O'Keefe, Mary
    O'Brien, Marisa
    Gonzalez, Mariela Cardona
    Hobbs, Brandon
    Pajoumand, Mehrnaz
    Peppard, William J.
    [J]. PHARMACOTHERAPY, 2024, 44 (03): : 258 - 267
  • [3] Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients
    Yam, Lily
    Bahjri, Khaled
    Geslani, Van
    Cotton, Adrian
    Hong, Lisa
    [J]. PHARMACOTHERAPY, 2019, 39 (07): : 749 - 755
  • [4] Safety and Efficacy of Prophylactic Enoxaparin Adjusted by Anti-Factor Xa Peak Levels in Pancreatic Surgery
    Kramme, Katherine
    Sarraf, Paya
    Shebrain, Saad
    Munene, Gitonga
    [J]. AMERICAN SURGEON, 2023, 89 (02) : 300 - 308
  • [5] Should we be following anti-factor Xa levels in patients receiving prophylactic enoxaparin perioperatively?
    Pannucci, Christopher J.
    Rondina, Matthew T.
    [J]. SURGERY, 2017, 161 (02) : 329 - 331
  • [6] Supratherapeutic anti-factor Xa levels in patients receiving prophylactic doses of enoxaparin: A case series
    Pannucci, Christopher J.
    Varghese, Thomas K.
    Graves, Kencee K.
    Prazak, Ann Marie
    [J]. INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2016, 28 : 114 - 116
  • [7] Anti-Factor Xa Activity of Prophylactic Enoxaparin Regimens in Critically Ill Patients
    Helviz, Yigal
    Dzigivker, Ilia
    Raveh-Brawer, David
    Hersch, Moshe
    Zevin, Shoshana
    Einav, Sharon
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016, 18 (02): : 108 - 113
  • [8] Assessment of enoxaparin thromboprophylaxis dosing and anti-factor Xa levels in low-weight patients.
    Yam, Lily
    Hong, Lisa
    [J]. PHARMACOTHERAPY, 2016, 36 (07): : E108 - E109
  • [9] Supraprophylactic Anti-Factor Xa Levels Are Associated with Major Bleeding in Neurosurgery Patients Receiving Prophylactic Enoxaparin
    May, Casey C.
    Cua, Santino
    Smetana, Keaton S.
    Powers, Ciaran J.
    [J]. WORLD NEUROSURGERY, 2022, 157 : E357 - E363
  • [10] ANTI-FACTOR XA LEVELS IN PICU PATIENTS ON ENOXAPARIN FOR VENOTHROMBOEMBOLISM PROPHYLAXIS
    Marshall, Amanda
    Malone, Matthew
    Yee, Addison
    [J]. CRITICAL CARE MEDICINE, 2019, 47
12345